| 发明名称 |
DEFECTIVE CYSTIC FIBROSIS TRANSDUCTION REGULATOR (CFTR) CAUSES INCREASED SPHINGOLIPID SYNTHESIS |
| 摘要 |
The invention relates to methods and compositions for treating cystic fibrosis and P. aeruginosa infections by administering a therapeutic amount of one or more agents that inhibit de novo sphingolipid synthesis or recycling pathways.
|
| 申请公布号 |
WO2008006007(A3) |
申请公布日期 |
2008.10.30 |
| 申请号 |
WO2007US72801 |
申请日期 |
2007.07.03 |
| 申请人 |
COLUMBIA UNIVERSITY;WORGALL, TILLA |
发明人 |
WORGALL, TILLA |
| 分类号 |
A61K31/16 |
主分类号 |
A61K31/16 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
